226400 — Osteonic Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩89bn
- KR₩92bn
- KR₩28bn
- 52
- 41
- 21
- 27
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 11,161 | 12,615 | 15,598 | 19,839 | 27,799 |
Cost of Revenue | |||||
Gross Profit | 5,029 | 5,495 | 6,502 | 8,730 | 13,051 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 11,363 | 15,610 | 16,101 | 18,708 | 23,453 |
Operating Profit | -202 | -2,996 | -503 | 1,131 | 4,346 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -126 | -6,495 | -5,438 | 2,081 | 1,781 |
Provision for Income Taxes | |||||
Net Income After Taxes | 499 | -5,381 | -2,852 | 836 | 3,658 |
Net Income Before Extraordinary Items | |||||
Net Income | 499 | -5,381 | -2,852 | 836 | 3,658 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 534 | -5,381 | -2,852 | 100 | 3,658 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 74.9 | -259 | -135 | 30.8 | 209 |
Dividends per Share |